Literature DB >> 18840420

GSTM1-null polymorphism as possible risk marker for hypertension: results from the aging and longevity study in the Sirente Geographic Area (ilSIRENTE study).

Ettore Capoluongo1, Graziano Onder, Paola Concolino, Andrea Russo, Concetta Santonocito, Roberto Bernabei, Cecilia Zuppi, Franco Ameglio, Francesco Landi.   

Abstract

BACKGROUND: Involvement of various gene mutations in hypertension have been already reported, including GST (detoxification Phase II enzymes), with contrasting results. This study analyzes a possible association between GSTM1-null and GSTT1-null polymorphisms and the hypertension status in a very old population (>80 years).
METHODS: 354 old patients were collected (255 were hypertensive and 99 were not).
RESULTS: GSTM1-null individuals (n=156) were significantly associated with increased risk of hypertension [OR=2.25 (1.36-3.72); p=0.005]. This association was confirmed both in 115 male and 239 female subjects. In contrast, no significant association was observed [p=0.52, OR=1.24 (0.67-2.29)] in the 57 hypertensive GSTT1-null genotypes vs 198 wild-type individuals. The above mentioned significances were obtained by multivariate logistic regression analysis after adjusting for confounder variables. Alcohol consumption and/or smoke habits were not significantly different between the two groups, as well as gender, marital status, education, number of concomitant diseases, and presence of cardiovascular diseases. No synergistic association was observed for the combined null genotypes of GSTT1 and GSTM1.
CONCLUSIONS: The knowledge of GSTM1 variant status seems to be potentially useful to predict a possible hypertensive status after 80 years of age. This study underlines a possible importance of the GSTM1 enzyme for blood pressure regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18840420     DOI: 10.1016/j.cca.2008.09.017

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

1.  Glutathione S-Transferase M1 and T1 polymorphisms and hypertension risk: an updated meta-analysis.

Authors:  Shu-Ling Rong; Xue-Dong Zhou; Ze-Kun Wang; Xiao-Lin Wang; Yu-Chuan Wang; Cun-Shui Xue; Bao Li
Journal:  J Hum Hypertens       Date:  2018-11-12       Impact factor: 3.012

2.  Glutathione S-transferase variants as risk factor for essential hypertension in Italian patients.

Authors:  Renato Polimanti; Sara Piacentini; Natalia Lazzarin; Maria Antonietta Re; Dario Manfellotto; Maria Fuciarelli
Journal:  Mol Cell Biochem       Date:  2011-06-09       Impact factor: 3.396

Review 3.  Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: a systematic review and meta-analysis of 12 studies.

Authors:  Saeid Eslami; Amirhossein Sahebkar
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

4.  GSTM1 Deletion Exaggerates Kidney Injury in Experimental Mouse Models and Confers the Protective Effect of Cruciferous Vegetables in Mice and Humans.

Authors:  Joseph C Gigliotti; Adrienne Tin; Shirin Pourafshar; Sylvia Cechova; Yves T Wang; Sun-Sang J Sung; Gabor Bodonyi-Kovacs; Janet V Cross; Guang Yang; Nhu Nguyen; Fang Chan; Casey Rebholz; Bing Yu; Megan L Grove; Morgan E Grams; Anna Köttgen; Robert Scharpf; Phillip Ruiz; Eric Boerwinkle; Josef Coresh; Thu H Le
Journal:  J Am Soc Nephrol       Date:  2019-11-14       Impact factor: 10.121

5.  Are centenarians genetically predisposed to lower disease risk?

Authors:  Jonatan R Ruiz; Carmen Fiuza-Luces; Amaya Buxens; Amalia Cano-Nieto; Félix Gómez-Gallego; Catalina Santiago; Gabriel Rodríguez-Romo; Nuria Garatachea; José I Lao; María Morán; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2011-09-06

Review 6.  GSTM1 Gene, Diet, and Kidney Disease: Implication for Precision Medicine?: Recent Advances in Hypertension.

Authors:  Thu H Le
Journal:  Hypertension       Date:  2021-08-30       Impact factor: 9.897

7.  Genetic polymorphism of drug metabolism enzymes (GSTM1, GSTT1 and GSTP1) in the healthy Malian population.

Authors:  Yaya Kassogue; Brehima Diakite; Oumar Kassogue; Issa Konate; Kadidiatou Tamboura; Zoumana Diarra; Hind Dehbi; Sellama Nadifi; Cheick Bougadari Traore; Sounkalo Dao; Seydou Doumbia; Guimogo Dolo
Journal:  Mol Biol Rep       Date:  2019-10-24       Impact factor: 2.316

8.  Association of glutathione S-transferase T1 and M1 gene polymorphisms with ischemic stroke risk in the Chinese Han population.

Authors:  Rui Wang; Yan Wang; Junhong Wang; Kun Yang
Journal:  Neural Regen Res       Date:  2012-06-25       Impact factor: 5.135

Review 9.  Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) null polymorphisms and the risk of hypertension: a meta-analysis.

Authors:  Beihai Ge; Yadong Song; Yi Zhang; Xiaowen Liu; Yuxiang Wen; Xiaomei Guo
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

10.  Investigate the Role of Glutathione S Transferase (GST) Polymorphism in Development of Hypertension in UAE Population.

Authors:  Kosar Hussain; Neveen Salah; Sahar Hussain; Sara Hussain
Journal:  Iran Red Crescent Med J       Date:  2012-08-30       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.